Latest Nutrition News

13May
2023

FDA Approves First Nonhormonal Drug to Ease Menopause Hot Flashes

FDA Approves First Nonhormonal Drug to Ease Menopause Hot FlashesSATURDAY, May 13, 2023 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes.The new pill, called Veozah (fezolinetant), is from a class of drugs called neurokinin 3 (NK3) receptor antagonists. It targets a specific brain neuron that's thought to be set off balance as estrogen levels naturally decline during menopause. "It works by binding to and blocking the activities of the NK3 receptor, which plays a role in the brain's regulation of body temperature," the FDA explained in a news release issued Friday."Hot flashes as a result of menopause can be a serious physical burden on women and impact their quality of life," said Dr. Janet Maynard, who directs the Office of Rare Diseases, Pediatrics,...

FDA Panel Recommends Approval of First Nasal Spray to...

12 May 2023
FDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergy AttacksFRIDAY, May 12, 2023 (HealthDay News) -- Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adults (16:6) and children (17:5), key questions linger about whether more data is needed from its maker, ARS Pharmaceuticals, CBS News reported.But Richard Lowenthal, co-founder, president and CEO at ARS, said in a company statement following the vote that, “We believe our clinical data from more than 600 individuals demonstrate Neffy’s absorption-enhancing nasal spray technology is comparable to injectable products in delivering potentially lifesaving epinephrine, but with...

FDA Eases Rules on Gay Men Donating Blood

11 May 2023
FDA Eases Rules on Gay Men Donating BloodTHURSDAY, May 11, 2023 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday finalized the elimination of certain restrictions that prevented healthy gay and bisexual men from donating blood. Instead of requiring men who have sex with men or the women who have sex with them to abstain for sexual contact for three months, the FDA has created an individual risk assessment for all donors. These questions are meant to reduce the risk of transfusion-transmitted HIV."The FDA has worked diligently to evaluate our policies and ensure we had the scientific evidence to support individual risk assessment for donor eligibility while maintaining appropriate safeguards to protect recipients of blood products. The implementation of these recommendations will represent a significant...

FDA Approves First Drug Meant to Ease Alzheimer's-Linked...

11 May 2023
FDA Approves First Drug Meant to Ease Alzheimer`s-Linked AgitationTHURSDAY, May 11, 2023 (HealthDay News) -- A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approved treatment for these symptoms.“Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease. ‘Agitation’ can include symptoms ranging from pacing or restlessness to verbal and physical aggression,” said Dr. Tiffany Farchione, director of the division of psychiatry in the FDA’s Center for Drug Evaluation and Research. “These symptoms are leading causes of assisted living or...

FDA Advisors OK Approval of First Over-the-Counter Birth Control Pill

10 May 2023
FDA Advisors OK Approval of First Over-the-Counter Birth Control PillWEDNESDAY, May 10, 2023 (HealthDay News) -- In a unanimous vote, a panel of expert advisors to the U.S. Food and Drug Administration on Wednesday endorsed the over-the-counter sale of a birth control pill, a recommendation that will likely pave the way for far greater access to contraception for Americans.Opill, as the pill is called, was first approved by the FDA in 1973. There is no precise information available on how much Opill will cost if sold over the counter (OTC), but Opill manufacturer Perrigo said recently that it is committed to making the medication affordable."Today’s vote to recommend a switch of Opill to OTC is a new, groundbreaking chapter in reproductive health. Perrigo is proud to lead the way in making contraception more accessible to women in the U.S.,” Perrigo...
RSS
123578910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.